EyePoint Pharmaceuticals
EYPT
EYPT
50 hedge funds and large institutions have $31.4M invested in EyePoint Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 17 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
32% less capital invested
Capital invested by funds: $46.2M → $31.4M (-$14.9M)
53% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 17
Holders
50
Holding in Top 10
1
Calls
$3K
Puts
–
Top Buyers
| 1 | +$91K | |
| 2 | +$66K | |
| 3 | +$42K | |
| 4 |
VF
Virtu Financial
New York
|
+$30K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$16.3K |
Top Sellers
| 1 | -$179K | |
| 2 | -$110K | |
| 3 | -$42K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$41.7K |
| 5 |
NAM
Nexpoint Asset Management
Dallas,
Texas
|
-$35K |